Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03537079
Other study ID # 38RC17.347
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 2020
Est. completion date May 2022

Study information

Verified date March 2020
Source University Hospital, Grenoble
Contact stephane doutreleau, MD, PhD
Phone + 33 4 76 76 77 73
Email sdoutreleau@chu-grenoble.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Heart failure impairs quality of life and exercise capacity, despite an optimal medical therapy. Alternative methods, like hypoxic conditioning coupled to exercise training, must be explored and describe


Description:

All heart failure patients will have a session of 45' of bicycle exercise training (in normoxia or hypoxia) AND a one hour rest session (in normoxia or hypoxia).

Exercise training sessions will consist in a continue bicycle exercise test at 70 to 80 % of the maximal heart rate, while breathing (single blind) normoxia or hypoxia gaz.

Rest conditioning consist in a one hour of rest, while breathing (single blind) normoxia or hypoxia gaz.

For hypoxia sessions, the oxygen saturation target will be fo 85-90 % for the 4 first weeks and 80-85 % for the last 4 weeks.

Three arms :

- exercise training in NORMOXIA and rest conditioning in NORMOXIA

- exercise training in HYPOXIA and rest conditioning in NORMOXIA

- exercise training in NORMOXIA and rest conditioning in HYPOXIA


Recruitment information / eligibility

Status Recruiting
Enrollment 63
Est. completion date May 2022
Est. primary completion date May 2021
Accepts healthy volunteers No
Gender All
Age group 20 Years to 70 Years
Eligibility Inclusion Criteria:

- patient available for exercise training

- stable heart failure state I-II New York Heart Association (NYHA) with altered ejection fraction (EF = 40 %)

- signed informed consent

Exclusion Criteria:

- unstable ischemic cardiopathy

- right ventricle dysfunction

- uncontrolled arrythmias

- rest elevated in pulmonary artery pressure (= 45 mmHg)

- migraine

- high altitude trip above 2500 m high during study period

- impossibility to realise a maximal bicycle exercise test

Study Design


Related Conditions & MeSH terms


Intervention

Other:
hypoxia air
Normobaric hypoxia is generated by adding azote in normal air to decrease the oxygen availability.

Locations

Country Name City State
France University Hospital Grenoble

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Grenoble

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary maximal oxygen uptake in ml/min/kg The maximal exercise capacity will be assessed by an incremental maximal bicycle exercise test after 8 weeks of training and conditioning
Secondary End diastolic left ventricle diameter in mm In parasternal long axe, the end diastolic left ventricle diameter After 8 weeks of training and conditioning
Secondary systolic left ventricle ejection fraction in % the systolic left ventricle ejection fraction will be assessed by Simpson's method in 4 and 2 cavity views After 8 weeks of training and conditioning
Secondary flow mediated dilatation (FMD) in % The rest FMD will be assessed by echocardiography by using the % of variation of the brachial artery diameter 10 minutes after occlusion. After 8 weeks of training and conditioning
Secondary systolic and diastolic blood pressure control in mmHg 24 hours ambulatory blood pressure monitoring After 8 weeks of training and conditioning
See also
  Status Clinical Trial Phase
Withdrawn NCT03227393 - The Effect of Yoga on Cardiac Sympathetic Innervation Evaluated by I-123 mIBG N/A
Recruiting NCT04528004 - Mechanistic Studies of Nicotinamide Riboside in Human Heart Failure Early Phase 1
Recruiting NCT04703842 - Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction Phase 1/Phase 2
Recruiting NCT04522609 - Electrostimulation of Skeletal Muscles in Patients Listed for a Heart Transplant N/A
Completed NCT05475028 - Network Medicine Approaches to Classify Heart Failure With PReserved Ejection Fraction by Signatures of DNA Methylation and Point-of-carE Risk calculaTors (PRESMET)
Not yet recruiting NCT06240403 - Digoxin and Senolysis in Heart Failure and Diabetes Mellitus Phase 2
Not yet recruiting NCT05988749 - Digital Remote Home Monitoring for Heart Failure N/A
Recruiting NCT04950218 - The Psoriasis Echo Study
Suspended NCT04701112 - Acute Hemodynamic Effects of Pacing the His Bundle in Heart Failure N/A
Completed NCT03305692 - ECG Belt vs. Echocardiographic Optimization of CRT N/A
Recruiting NCT05933083 - MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation N/A
Enrolling by invitation NCT03903107 - The Fluoroless-CSP Trial Using Electroanatomic Mapping N/A
Withdrawn NCT04872959 - TRANSFORM Heart Failure With Reduced Ejection Fraction N/A
Completed NCT02920918 - Treatment of Diabetes in Patients With Systolic Heart Failure Phase 4
Completed NCT02334891 - Kyoto Congestive Heart Failure Study
Recruiting NCT03553303 - Pharmacodynamic Effects of Sacubitril/Valsartan on Natriuretic Peptides, Angiotensin and Neprilysin Phase 4
Recruiting NCT04083690 - Multi-lead ECG to Effectively Optimize Resynchronization Devices: New CRT Recipients N/A
Recruiting NCT03830957 - Efficacy and Safety of Ivabradine to Reduce Heart Rate Prior to Coronary CT-angiography in Advanced Heart Failure: Comparison With β-Blocker N/A
Recruiting NCT06121323 - Physiological Effects of Lactate in Individuals With Chronic Heart Failure N/A
Completed NCT03351283 - Effect of Sodium Intake on Brain Natriuretic Peptide Levels in Patients With Heart Failure N/A